Comment on “Epidemiology and Clinical Characteristics of Fatty Pancreas Disease in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review”

Key Points

• The aim is to analyze the epidemiology and clinical characteristics of fatty pancreas disease in relation to metabolic dysfunction-associated steatotic liver disease.
• Systematic review of existing literature on fatty pancreas disease and its connection to metabolic dysfunction.
• Analysis of clinical characteristics and prevalence data related to fatty pancreas disease.
• No datasets were generated or analyzed for this article, focusing solely on existing literature findings.
• Highlights the growing recognition of fatty pancreas disease within metabolic dysfunction contexts.